Treatment outcomes for 618 women with gestational trophoblastic tumours following a molar pregnancy at the Charing Cross Hospital, 2000-2009

British Journal of Cancer

Volumn 107, Issue 11, 2012, Pages 1810-1814

  Sita Lumsden, A ^a   Short, D ^a   Lindsay, I ^a   Sebire, N J ^a   Adjogatse, D ^a   Seckl, M J ^a   Savage, P M ^a  

^a IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

demographics; gestational trophoblastic tumours; methotrexate resistance; molar pregnancy

Indexed keywords

CHORIONIC GONADOTROPIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETOPOSIDE; FOLINIC ACID; METHOTREXATE; VINCRISTINE;

ADULT; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; FEMALE; FOLLOW UP; HUMAN; HYDATIDIFORM MOLE; HYSTERECTOMY; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TABLET; TREATMENT DURATION; TROPHOBLASTIC TUMOR; UNITED KINGDOM;

ADULT; CHORIONIC GONADOTROPIN; FEMALE; GESTATIONAL TROPHOBLASTIC DISEASE; HUMANS; HYDATIDIFORM MOLE; LEUCOVORIN; METHOTREXATE; PREGNANCY; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84870058439     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.462     Document Type: Review

References (20)

1. Aghajanian C (2011) Treatment of low-risk gestational trophoblastic neoplasia. J Clin Oncol 29: 786-788
2. Alazzam M, Tidy J, Hancock BW, Osborne R (2009) First line chemotherapy in low risk gestational trophoblastic neoplasia. Cochrane Database Syst Rev 1: CD007102
3. Bower M, Newlands ES, Holden L, Short D, Brock C, Rustin GJ, Begent RH, Bagshawe KD (1997) EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients. J Clin Oncol 15: 2636-2643
4. Bower M, Rustin GJ, Newlands ES, Holden L, Short D, Foskett M, Bagshawe KD (1998) Chemotherapy for gestational trophoblastic tumours hastens menopause by 3 years. Eur J Cancer 34: 1204-1207
5. Chalouhi GE, Golfier F, Soignon P, Massardier J, Guastalla JP, Trillet-Lenoir V, Schott AM, Raudrant D (2009) Methotrexate for 2000 FIGO low-risk gestational trophoblastic neoplasia patients: efficacy and toxicity. Am J Obstet Gynecol 200: 643.e1-643.e6
6. El-Helw LM, Coleman RE, Everard JE, Tidy JA, Horsman JM, Elkhenini HF, Hancock BW (2009) Impact of the revised FIGO/WHO system on the management of patients with gestational trophoblastic neoplasia. Gynecol Oncol 113: 306-311
7. Fülöp V, Szigetvári I, Szepesi J, Végh G, Bátorfi J, Nagymányoki Z, Török M, Berkowitz RS (2010) 30 years' experience in the treatment of low-risk gestational trophoblastic neoplasia in Hungary. J Reprod Med 55: 253-257
8. Growdon WB, Wolfberg AJ, Goldstein DP, Feltmate CM, Chinchilla ME, Lieberman ES, Berkowitz RS (2010) Low-risk gestational trophoblastic neoplasia and methotrexate resistance: predictors of response to treatment with actinomycin D and need for combination chemotherapy. J Reprod Med 55: 279-284
9. Hertz R, Li MC, Spencer DB (1956) Effect of methotrexate therapy upon choriocarcinoma and chorioadenoma. Proc Soc Exp Biol Med 93: 361-366
10. Hoekstra AV, Lurain JR, Rademaker AW, Schink JC (2008) Gestational trophoblastic neoplasia: treatment outcomes. Obstet Gynecol 112: 251-258
11. Homesley HD (1994) Development of single-agent chemotherapy regimens for gestational trophoblastic disease. J Reprod Med 39: 185-192
12. Kang WD, Choi HS, Kim SM (2010) Weekly methotrexate (50 mg/m(2)) without dose escalation as a primary regimen for low-risk gestational trophoblastic neoplasia. Gynecol Oncol 117: 477-480
13. Lertkhachonsuk AA, Israngura N, Wilailak S, Tangtrakul S (2009) Actinomycin d versus methotrexate-folinic acid as the treatment of stage I, low-risk gestational trophoblastic neoplasia: a randomized controlled trial. Int J Gynecol Cancer 19: 985-988
14. McGrath S, Short D, Harvey R, Schmid P, Savage PM, Seckl MJ (2010) The management and outcome of women with post-hydatidiform mole 'lowrisk' gestational trophoblastic neoplasia, but hCG levels in excess of 100 000 IU l(-1). Br J Cancer 102: 810-814
15. McNeish IA, Strickland S, Holden L, Rustin GJ, Foskett M, Seckl MJ, Newlands ES (2002) Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000. J Clin Oncol 20: 1838-1844
16. Ngan HY, Bender H, Benedet JL, Jones H, Montruccoli GC, Pecorelli S (2003) Gestational trophoblastic neoplasia, FIGO 2000 staging and classification. Int J Gynaecol Obstet 83(S1): 175-177
17. Rustin GJ, Newlands ES, Lutz JM, Holden L, Bagshawe KD, Hiscox JG, Foskett M, Fuller S, Short D (1996) Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors. J Clin Oncol 14: 2769-2773
18. Savage P, Seckl M, Short D (2008) Practical issues in the management of low-risk gestational trophoblast tumors. J Reprod Med 53: 774-780
19. Seckl MJ, Sebire NJ, Berkowitz RS (2010) Gestational trophoblastic disease. Lancet 376: 717-729
20. Wang J, Short D, Sebire NJ, Lindsay I, Newlands ES, Schmid P, Savage PM, Seckl MJ (2008) Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/cisplatin alternating with paclitaxel/etoposide (TP/TE). Ann Oncol 19: 1578-1583